HealthcareServices

Veterinary Clinical Trials Market Forecast: How Big Will It Be by 2030?

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the veterinary clinical trials market from 2026–2035 with trusted insights from The Business Research Company

How is the Veterinary Clinical Trials Market size predicted to change over the forecast window of 2026–2035?

The veterinary clinical trials market size has demonstrated robust growth in recent years. It is projected to expand from $4.85 billion in 2025 to $5.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.7%. This expansion during the historic period can be ascribed to several factors, including the increase in veterinary pharmaceutical research, higher rates of pet ownership, a growing need for evidence-based veterinary treatments, the broadening of academic research programs, and improved regulatory frameworks for animal trials.

The veterinary clinical trials market size is projected to experience robust expansion over the upcoming years. This market is predicted to reach $7.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the forecast period is primarily driven by several factors, including escalating investments in the development of veterinary drugs, the increasing embrace of precision medicine in animal care, the broader participation of Contract Research Organizations (CROs) in veterinary trials, a heightened emphasis on chronic and oncology conditions, and the greater utilization of real-world evidence within animal health. Key trends anticipated for this period encompass the growing integration of digital platforms for trial management, an uptick in the application of genomic and biomarker-driven studies, an intensified focus on clinical research concerning companion animals, the proliferation of multicenter veterinary trials, and a strengthened commitment to data integrity and adherence to regulations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20683&type=smp

Which Drivers Are Contributing To The Expansion Of The Veterinary Clinical Trials Market?

An anticipated surge in pet ownership is set to drive the expansion of the veterinary clinical trials market. This practice entails keeping and nurturing animals as household companions. The increase in pet ownership is influenced by various factors, such as the human need for companionship, the therapeutic advantages of pets, and a heightened understanding of their beneficial effects on mental and physical well-being. Pet owners benefit from veterinary clinical trials by gaining access to innovative treatments and advanced veterinary care for their animals, leading to improved health outcomes. Additionally, these trials aid in the development of safer and more potent therapies. As an illustration, a survey by Petfood Industry, a US-based pet food manufacturer, reported approximately 68 million dogs owned by American households in June 2025, an increase from 65.1 million recorded in their 2023–2024 study. Thus, the expanding population of pet owners serves as a primary impetus for the veterinary clinical trials market’s expansion.

What Segment Classifications Make Up The Veterinary Clinical Trials Market?

The veterinary clinical trials market covered in this report is segmented –

1) By Animal: Livestock Animal, Companion Animal, Other Animals

2) By Indications: Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology, Ophthalmology, Dermatology, Other Indications

3) By Intervention: Medicines, Medical Devices, Other Interventions

4) By End-Users: Academics And Research Centers, Pharmaceutical And Biopharmaceutical Companies, Other End-Users

Subsegments:

1) By Livestock Animal: Cattle, Sheep, Goats, Swine, Poultry

2) By Companion Animal: Dogs, Cats, Horses, Rabbits, Ferrets

3) By Other Animals: Wildlife, Exotic Pets, Laboratory Animals, Aquatic Animals

Which Trends Are Influencing The Performance And Direction Of The Veterinary Clinical Trials Market?

Companies operating within the veterinary clinical trials market are heavily investing in the creation of innovative anti-aging drugs, seeking to extend pet longevity and improve general animal health. These novel anti-aging drugs are defined as advanced medications crafted to decelerate or even reverse the aging process, thereby enhancing the vitality and health of aging animals. For example, in February 2024, Loyal, a veterinary company based in the US, initiated a clinical trial for LOY-002, a new anti-aging drug aimed at increasing the healthy lifespan of senior dogs. This drug is designed to boost metabolic health in dogs, targeting age-related changes that frequently lead to various health issues. The chewable pill, specifically formulated for older dogs of most sizes (excluding the smallest breeds), is currently being assessed in the STAY study, which aims to enlist over 1,000 dogs aged 10 and above from more than 50 veterinary clinics across the United States. LOY-002’s primary objective is to improve metabolic function, with the potential to delay age-related diseases and significantly enhance the overall quality of life for aging canines.

Which Major Firms Are Strengthening Their Position In The Veterinary Clinical Trials Market?

Major companies operating in the veterinary clinical trials market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Charles River Laboratories International Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Hill’s Pet Nutrition Inc., Ethos Veterinary Health LLC, Orion Corporation, Dechra Pharmaceuticals plc, Morris Animal Foundation, Vaxine Pty Ltd, Bioagile Therapeutics Pvt. Ltd., VetStem Inc., VetDC, Vivesto AB, OCRvet, Vetbiolix, Clinvet International, Ondax Scientific S.l., Veterinary Research Management

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-clinical-trials-global-market-report

Which Regions Are Poised For Strategic Growth In The Veterinary Clinical Trials Market?

North America was the largest region in the veterinary clinical trials market in 2025. The regions covered in the veterinary clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Clinical Trials Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20683&type=smp

Browse Through More Reports Similar to the Global Veterinary Clinical Trials Market 2026, By The Business Research Company

Veterinary Imaging Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-equipment-global-market-report

Companion Animal Veterinary Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Veterinary Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-disposables-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795